Aurobindo Pharma Sees 13.1% Surge in Open Interest, Reaching 65,984 Contracts

Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 65,984 contracts, reflecting a rise of 7,642 contracts or 13.1% from the previous open interest of 58,342. This uptick coincides with a trading volume of 39,621 contracts, indicating active participation in the market.
In terms of price performance, Aurobindo Pharma has outperformed its sector by 0.39%, with a 1-day return of 0.41%. The stock has shown consistent gains over the past two days, accumulating a total return of 0.46% during this period. Notably, the stock’s current price is above its 20-day and 50-day moving averages, although it remains below the 5-day, 100-day, and 200-day moving averages.

Despite this positive momentum, there has been a notable decline in investor participation, with delivery volume on October 21 dropping by 93.72% compared to the 5-day average. The liquidity remains adequate for trades up to Rs 1.2 crore, based on 2% of the 5-day average traded value. Overall, the increase in open interest highlights a notable shift in market dynamics for Aurobindo Pharma.